Impact of Blood Sugar Levels on Fracture Risk in Type 1 Diabetes

Introduction to Type 1 Diabetes

Diabetes is a global health concern, affecting millions of individuals. Type 1 diabetes, often referred to as juvenile diabetes, can develop at a young age when the pancreas fails to produce insulin. This deficiency results in poor blood sugar management and can lead to various complications, including kidney disease, eye problems, and an increased risk of fragility fractures.

Study Overview

A recent study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism aimed to explore the connection between blood sugar control in diabetes and the incidence of non-vertebral low-trauma fractures. Researchers selected participants diagnosed with type 1 and type 2 diabetes from a primary care database in the UK. The study spanned 21 years, from 1995 to 2015, and participants were categorized into two groups: cases and controls.

Methodology

Participants who experienced a fragility fracture during the study were classified as cases, with the date of their fracture designated as the index date. Those without fractures from disease onset to the index date comprised the control group. The researchers monitored the duration of diabetes and the HbA1c levels, which reflect blood glucose levels.

Findings on Fracture Risk

Among the participants, 9,531 had fractures. Findings indicated that type 1 diabetes patients with well-controlled blood sugar showed no increased risk of fragility fractures. In contrast, those with poor glycemic control—defined as HbA1c levels of 8% or higher—demonstrated a heightened risk of low-trauma fractures, a trend not observed in type 2 diabetes patients. On average, fractures occurred in patients who had diabetes for 4.5 years.

Impact of High Blood Sugar on Bone Health

Elevated blood glucose levels in type 1 diabetes adversely affect osteoblast function, reduce bone mineral content, and disrupt calcium and vitamin D metabolism, ultimately impairing bone quality and increasing fracture risk. Conversely, in type 2 diabetes, insulin resistance leads to elevated blood insulin levels, which can stimulate bone-forming cells. However, patients treated with anti-diabetic medications such as rosiglitazone and pioglitazone experienced a two- to three-fold increase in fracture risk due to accelerated bone loss.

Study Strengths and Limitations

This study presents several strengths, including a substantial participant pool that reflects the general population. The glycemic status of patients was regularly monitored through multiple HbA1c assessments over the study’s duration. Additionally, the analysis distinguished between type 1 and type 2 diabetes.

However, limitations exist, such as the inclusion of many healthy, well-controlled type 2 diabetes patients. Factors like medications and other health conditions affecting fracture risk were not excluded, and the specific causes of fractures were not examined.

Importance of Patient Education

Dr. Janina Vavanikunnel from the University Hospital Basel stated, “We investigated the association between the degree of glycemic control and fracture risk by using a large cohort of newly diagnosed type 1 and type 2 diabetes patients. Both types of diabetes are associated with fragility fractures, and we showed that poor glycemic control is linked to an increased risk of fracture in type 1 diabetes.”

Conclusion

The study concludes that poor blood sugar control in type 1 diabetes is associated with a higher risk of fragility fractures. Enhancing patient education and motivation can play a crucial role in mitigating this risk and improving the overall quality of life for individuals with diabetes.

References

1. Higher risk of fracture in type 1 diabetes may be linked to poor blood sugar control [Internet]. EurekAlert!. 2019 [cited 7 March 2019]. Available from: https://www.eurekalert.org/pub_releases/2019-01/tes-hro011519.php
2. Vavanikunnel, J., Charlier, S., Becker, C., Schneider, C., Jick, S., Meier, C., & Meier, C. (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. The Journal Of Clinical Endocrinology & Metabolism, 104(5), 1645-1654. doi: 10.1210/jc.2018-01879